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Abstract
The chemokine CCL20, the unique ligand of CCR6 functions as an attractant of immune cells. Expression of CCL20 is induced
by Toll-like Receptor (TLR) signaling or proinflammatory cytokine stimulation. However CCL20 is also constitutively
produced at specific epithelial sites of mucosa. This expression profile is achieved by transcriptional regulation. In the
present work we characterized regulatory features of mouse Ccl20 gene. Transcriptional fusions between the mouse Ccl20
promoter and the firefly luciferase (luc) encoding gene were constructed and assessed in in vitro and in vivo assays. We
found that liver CCL20 expression and luciferase activity were upregulated by systemic administration of the TLR5 agonist
flagellin. Using shRNA and dominant negative form specific for mouse TLR5, we showed that this expression was controlled
by TLR5. To address in situ the regulation of gene activity, a transgenic mouse line harboring a functional Ccl20-luc fusion
was generated. The luciferase expression was highly concordant with Ccl20 expression in different tissues. Our data indicate
that the transgenic mouse model can be used to monitor activation of innate response in vivo.
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Introduction
Chemokines are small proteins that play a major role in the
chemotactic movement of cells along the body. They are critical
for the proper positioning of immune cells and the development of
immune responses. Thus, the expression of chemokines is highly
regulated [1]. Chemokines can be divided into constitutive and
inducible chemokines with regards to their function. Constitutively
expressed chemokines contribute at steady state to positioning of
immune cells in lymphoid and non lymphoid organs [2]. Inducible
chemokines are swiftly and transiently expressed upon stimulation
by external factors and promotes the migration of immune cells to
stimulation sites [3]. In pro-inflammatory immune responses
triggered during infection, inducible chemokines orchestrate the
entry of leukocytes such as neutrophils or inflammatory monocytes
into the site of injury.
Some chemokines may participate in both homeostatic and
alarm-driven functions. The chemokine CCL20 (or LARC for
liver- and activation-regulated chemokine) is constitutively ex-
pressed in specific sites such as follicle-associated epithelium of
Peyer’s patches, isolated lymphoid follicles and tonsils. In addition,
the production of CCL20 is strongly upregulated by various
danger stimuli in different organs such as liver, intestine or lung
and also mucosal sites [4–7]. The gene coding for CCL20
represents a stereotypical signature of innate response to infection
as determined by meta-analysis of microarray data [8,9]. CCR6,
the unique receptor of CCL20, is expressed by B cells, activated T
cells (particularly Th17), regulatory T cells, immature DC or
innate lymphoid cells [10–14]. How CCL20 participates in
constitutive and inducible arms of immunity is supported by the
analysis of the promoters from human (CCL20) and mouse (Ccl20)
genes [15–18]. Conserved motifs specific for binding of transcrip-
tion regulators were identified, including the canonical NF-kB and
the Ets (E-twenty six) family binding sites [15,17,19] The
promoters of CCL20 encoding genes are interesting candidates
for the establishment of reporter systems. We have previously
characterized the CCL20 human promoter gene and generated
stable reporter human intestinal cell lines [19,20] to investigate
how microbial products regulate the transcriptional activity of the
gene [21,22].
The flagellin family, the major constituent of bacteria flagella,
forms the unique agonist of Toll-like receptor 5 (TLR5) signaling
[23]. Whereas there are differences in human and mouse TLR5
sequences, the specific recognition of flagellins seems to require
similar TLR5 determinants [24]. Remarkably, a stop mutation of
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Figure 1. Functional characterization of Ccl20-luc transcriptional fusions. A. Alignment of human and mouse CCL20 promoters. Position +1
indicate initiation site for transcription and first codon is highlighted in grey. * indicates homology in the sequence alignment. Critical features and
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human TLR5 (1–392) acts as a dominant negative mutant on
TLR5 signaling [25]. MyD88 is an essential adaptor molecule for
TLR5 signaling since responses are totally abolished in MyD88-
knockout animals [26,27]. TLR5 stimulates transcription of pro-
inflammatory genes dependent on NF-kB and MAPKs. Interest-
ingly, flagellins signal very efficiently in both hematopoietic cells
including dendritic cells, and stromal cells, especially intestinal
epithelial cells or liver cells [6,28,29]. Thus, flagellin is a potent
activator of CCL20 in human and mouse systems [30], thereby
constituting an appropriate way to address regulation of gene
coding CCL20.
In this work, we characterized regulatory features of the mouse
Ccl20 gene and generated a mouse reporter system. To this aim,
transcriptional fusions between the Ccl20 promoter and the firefly
luciferase (luc) encoding gene were constructed and assessed in
in vitro and in vivo assays. Flagellin was used to evaluate the
function of promoter and the specificity of regulation with shRNA
against Tlr5 and a dominant form of mouse TLR5 (TLR5393stop).
A functional Ccl20-luc fusion was finally integrated in a mouse line
to address in situ the regulation of gene activity. We showed that
this model can be used to monitor activation of innate response
in vivo, with maximal expression in the liver.
Materials and Methods
Animals
BALB/cJ, C57BL/6J and the transgenic line U68 harboring the
Ccl20-luc-IRES-EYFP construct were bred at the SPF animal
facility of the Transgenic and Experimental Animal Unit of
Institut Pasteur de Montevideo or Institut Pasteur de Lille
(agreement#A59-350009). NFkB-RE-luc mice were purchased
from Taconic (Germantown, NY, USA). Experimental procedures
complied with international FELASA guidelines, national regula-
tions and ethical guidelines (French protocol CEEA 052011 and
Uruguayan Animal Care Committee) and all experimental
procedures involving animals were approved by the corresponding
Institutional Animal Care Committees of either Institut Pasteur de
Lille or Institute Pasteur de Montevideo.
Plasmid Constructs
The Ccl20 gene (about 1.4 kb of promoter and 1.0 Kb of
transcribed gene) was originally amplified using the following
primers: CTCGAGCACAATGGAGAGGAATGACCA (XhoI) and
AAGCTTATGTACGAGAGGCAACAGTCG (HindIII). The pro-
moter was then cloned using XhoI and the endogenous KpnI site
close to the start of transcription (Figure 1A) into the firefly
luciferase reporter pGL-3 basic vector (Promega, USA). The
resulting construct pCcl20-luc (21377/+11) harbors 1388 bp
(1377 bp upstream transcription start site and 11 bp of transcribed
region) of the Ccl20 promoter region. To generate the transgenic
animals, an IRES-EYFP cassette obtained from Dr. Richard M.
Locksley [31] was cloned downstream the luc cDNA of pCcl20-luc
to give rise to the plasmid pCcl20-luc-IRES-eyfp. We also used the
reporter plasmids harboring Ccl20 promoters 2299/+6, 285/+6,
2299/+6 (NF-kB mutant) and luc fusions previously described by
Fujiie et al. [15]. An Ets-1 mutant fusion was constructed using the
2299/+6 reporter fusion as template to change the (2156)
GCAGGAAGT (2147) Ets-1 site in GCATTCAGT. To define
the TLR5 specificity of flagellin response, two sets of constructs
were used. First, plasmids expressing functional shRNA under the
control of 7SK promoter targeting Tlr5 or coding for a scrambled
shRNA sequence (Invivogen, France). Second, the cDNA coding
for the recombinant mouse TLR5 (residues 1 to 392 with codon
393 changed in a stop codon), a sequence equivalent to the
dominant negative human TLR5 [25] was cloned into the HindIII
and NotI sites of the vector pcDNA3 using the PCR fragment
obtained with primers: AAGCTTGGATCATGGCATGT-
CAACTTGACTTGC and GCGGCCGCTCAGAGATC-
TAAGGTTTGTAACG. All plasmids were verified by re-
sequencing.
Hydrodynamic Shock Injections
BALB/c mice were injected with combination of plasmids
diluted in 1.4 mL Ringer solution (147 mM NaCl, 4 mM KCl,
1.13 mM CaCl2, pH 7.5) via tail vein as described previously [32].
Typically, 25 mg Firefly luciferase reporter plasmid (Ccl20
promoter) and 2.5 mg Renilla luciferase plasmid pRL-TK
(Promega) for the normalization of transfection efficiency
625 mg plasmid for interference or dominant negative or control
plasmids, were used for each animal. Plasmid injection was
completed in less than 5 s and the level of activation of reporter
plasmids was assessed 48 h later. For this purpose, animals were
injected i.v. with 200 ml PBS 65 mg flagellin as described
previously [19,21]. Different organs including the liver, spleen,
or lung were sampled 6 h later to measure luciferase activity
(Firefly and Renilla), using Dual-Luciferase Assay (Promega),
following manufacturer instructions.
Generation and Analysis of Transgenic Animals
Transgenic animals were generated on a C57BL/6J genetic
background at the Institut Clinique de la Souris in Strasbourg,
France. Briefly, the plasmid pCcl20-luc-IRES-eyfp was purified and
injected in fertilized eggs from C57BL/6J. Several offspring
founders were generated and identified by PCR genotyping and
bred with C57BL/6J to produce F1. The first screening to identify
interesting reporter animals was performed on the F2 generation
by administration of flagellin and measurement of luciferase
transcription factor binding sites are underlined. B. Schematic representation of the different reporter constructs. (luc: firefly luciferase gene, pA:
polyadenylation signal). ‘‘IRES’’ stands for internal ribosome entry site. The cDNA eyfp encodes the enhanced yellow fluorescent protein. Positions
related to promoter are coincident with panel A. C. Functional analysis of Ccl20-luc in vivo. BALB/c mice were transfected for 48 h by hydrodynamic
shock with Ccl20-luc and TK-renilla plasmids, treated next i.v. for 8 h (5 mg flagellin or PBS), and liver luciferase activity was determined. Results are
expressed as relative luciferase activity using PBS-treated mice as reference and renilla activity as normalizer for transfection efficiency. Data are given
as mean 6 SD (n = 8; * p,0.05 Mann-Whithney test) and are representative of two experiments. D. NF-kB site but not Ets1 site is required for the
activation of transcriptional fusion by flagellin. Experiments were conducted as described in C using different luciferase reporter Ccl20-luc[2299–+6]
plasmids harboring deletions or mutations as shown in B. E. Liver response induced by flagellin depends on TLR5. Experiments were conducted as
described in C using Ccl20-luc, TK-renilla and TLR5shRNA or control scramble plasmid. In addition to flagellin, a group of animals was treated i.v. with
5 mg LPS. Data are given as mean 6 SD (n = 6–8; * p,0.05 n.s.: non significant differences, Mann-Whithney test) and are representative of three
experiments. F. Liver response induced by flagellin is TLR5 dependent. Experiments were conducted as described in C using Ccl20-luc, TK-renilla and
dominant negative TLR5393stop or control pcDNA3 plasmids. Data are given as mean 6 SD (n = 6–8; * p,0.05 n.s.: non significant differences, Mann-
Whithney test) and are representative of two experiments. G. Functional analysis of the Ccl20-luc-IRES-eyfp transcriptional fusion to be used for
transgenic mice generation. Experiments were conducted as described in C using Ccl20-luc-IRES-eyfp. Data are given as mean 6 SD (n = 8; * p,0.05
Mann-Whithney test) and are representative of two experiments.
doi:10.1371/journal.pone.0078447.g001
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activity in differen organs (see below). Classical genotyping of mice
was performed on tail genomic DNA using the following set of
primers for control (Cpxm1-F: ACTGGGATCTTC-
GAACTCTTTGGAC and Cpxm1-R: GATGTTGGGG-
CACTGCTCATTCACC), 59-amplification of construct (D-F:
GTGACAGGATGAGGCAGATTAATCAATGGG and D-R:
CTTTACCAACAGTACCGGAATGCCAAG), and 39-amplifi-
cation of construct (F-F: GCCCAGAAGGTACCCCATTG-
TATG and F-R: GTTTACGTCGCCGTCCAGCTC). In some
assays, genomic DNA was assessed using real time quantitative
PCR with the following primers specific for luc (LUC-F:
TGAGTACTTCGAAATGTCCGTTC and LUC-R: GTATT-
CAGCCCATATCGTTTCAT) and Actb (Actb-F: CGTCATC-
CATGGCGAACTG and Actb-R:
GCTTCTTTGCAGCTCCTTCGT). Since Ccl20-luc-IRES-eyfp
expression was stable over F1 to F8 (not shown), one can consider
that the germline transmission of transgene is effective and not
subjected to attenuation of expression.
Figure 2. Characterization of Ccl20-luc-IRES-eyfp transgenic line. Transgenic mice were treated with 5 mg flagellin or PBS i.v. and were sacrified
at indicated times. Organs were recovered for determination of luciferase activity or Ccl20 expression. A. Analysis of fusion expression in several
tissues after flagellin stimulation. Luciferase activity was measured 4 h post-treatment. Results are expressed as relative luciferase activity using PBS-
treated mice as reference. Data (n = 8) are given as mean 6 SD and are representative of two experiments. B. Flagellin-specific upregulation of Ccl20
transcription in tissues. Ccl20 mRNA levels were measured in different organs by RT-qPCR 4 h post-treatment. Results are expressed as relative mRNA
levels using to PBS treated mice as reference. Data (n = 5) are given as mean 6 SD and are representative of two experiments. C. Kinetics of liver
activation by flagellin as measured by fusion expression. Luciferase activity was measured in liver at different times after treatment. Results (n = 7) are
expressed as in A. D. Kinetics of liver activation by flagellin as measured by mRNA levels. Ccl20 mRNA level measured by RT-qPCR at 4 h and 24 h.
Results (n = 5) are expressed as in C.
doi:10.1371/journal.pone.0078447.g002
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Transgenic animals were stimulated with heat-inactivated
Salmonella enterica (108 CFU) or flagellin from Salmonella
typhimurium (5 mg/animal) (FLA-ST, InvivoGen, San Diego, CA,
USA) via i.p. or i.v routes for 4 h or as indicated.
Luciferase Assays
At indicated times, mice were sacrificed by cervical dislocation
or pentobarbital injection and samples of liver, spleen, lung and
small intestine were homogenized in lysis buffer (Luciferase Assay
System, Promega, MA, USA) using an ultra-turrax equipment
(T10 basic, IKA, Staufen, Germany). Luciferase activity was
determined using Luciferase Assay System by measuring the
bioluminescence emission in plate luminometer (LUMIstar
OPTIMA, BMG labtech, Ortenberg, Germany) according to
manufacturer’s instructions.
Gene Expression Analysis
After stimulation, animals were sacrificed, organs recovered and
homogenized in RA1 lysis buffer (GE Healthcare, Pittsburgh,
USA) and total RNA was extracted with Nucleo Spin RNA II kit
(Macherey-Nagel, Du¨ren, Germany). Reverse transcription was
performed using 200 U M-MLV reverse transcriptase (Invitrogen,
USA), 0.5 mM dNTPs, 1 nM random primers, 20 U RNAse-
OUT, 7.5 mM DTT, 1X reaction buffer and 400 ng of RNA in a
final volume of 20 ml. The RT reaction was performed at 25uC for
10 minutes followed by 37uC for 60 minutes. For real-time PCR,
MyiQ Single color Real-time PCR Detection System (BioRad,
Hercules, CA, USA) and SYBRH Green Master Mix (Invitrogen)
were used. A standard protocol of 40 cycles of denaturation 15 sec
at 90uC and annealing/extension 1 min 60uC amplification was
used. Primers for pro-inflammatory CCL20 and mouse b-actin
were previously designed and described [20,33]. Relative mRNA
expression of each chemokine was evaluated through the 2-DDCt
method and the b-actin gene was used as normalizer gene [20].
In vivo Imaging Experiments
A comparative analysis of the effect of the two agonists of the
innate immunity described before was done when administered via
i.p. and i.v. in CCL20-luc-IRES-eyfp and NFkB-luc control mice of 8
to 12 weeks of age. Activity of the reporter gene was studied in
different organs by in vivo imaging at 4, 8, 12 and 24 h pos-
stimulation, through injection of 150 mg/kg of luminogenic
substrate for luciferase (D-Luciferin Firefly, Caliper Life Sciences,
MA, USA), keeping the animal anesthetized with isofluorane
(Isoforine, Cristalia, SP, Brazil) for 5 min in in vivo imaging
analysis system (MS FX PRO, Carestream Health Inc, USA).
Intensity of innate response activation in different organs was
evaluated using the software Carestream molecular imaging v
5.3.3.17476.
For Ccl20-luc reporter mice, an imaging capture protocol of
5 min exposure was established, in comparison of a shorter
protocol used for the NF-kB model. In both cases, a previous X-
ray exposure followed by the bioluminescence filter was per-
formed. Images obtained from each animal were regionalized
(ROI) in three for Ccl20-luc-IRES-eyfp mice: thorax, upper
abdomen and middle abdomen, and in five for NF-kB mice:
head and neck, thorax, upper abdomen, middle abdomen and
lower abdomen. For each ROI the software calculated net and
mean intensity of photon emission per mm2, plotting average 6
SE for each treatment and acquisition time.
Results
Construction and Characterization of Mouse Ccl20
Reporter Fusions
With the aim to generate a reporter mouse strain, the Ccl20
gene promoter was linked to the Firefly luciferase gene luc, giving
rise to a transcriptional fusion (Figure 1). The 1388 bp fragment
that was used as the Ccl20 promoter contains 1377 bp upstream
the initiation of transcription site of murine Ccl20 gene as defined
previously by Fujiie et al. [15] (Figure 1A–B). By transient
transfection on human epithelial cell lines Caco-2 and HEK293,
functional activity of reporter upon pro-inflammatory stimulation
by the TLR5 agonist flagellin was confirmed (data not shown).
The activity of the reporter fusion was next assessed in vivo using
hydrodynamic shock injection followed by stimulation with
flagellin (Figure 1C). This approach allowed a transient transfec-
tion of mouse liver cells with the plasmid(s) injected by the i.v.
route. The flagellin stimulation was able to induce .100-fold the
luciferase activity in liver in contrast to PBS-stimulation of
transfected animals. These results are in accordance with previous
reports indicating that flagellin increases liver pro-inflammatory
transcription [29].
Additional experiments were performed to further characterize
the activity of the reporter in response to flagellin stimulation.
First, we defined that NF-kB site is essential to the activity of the
Ccl20 promoter using the constructs of Fujiie et al. [15]. Indeed,
reporter fusions deleted (285/+6) or mutated within the NF-kB
site were totally abrogated in the capacity to respond to flagellin
(Figure 1D). We also generated a fusion harboring a mutation in
the Ets-1 site (2156/2147). This mutation did not affect the
response to flagellin, thereby indicating that the liver response is
dominated by pro-inflammatory NF-kB signaling (Figure 1D).
Next, we assessed the role of direct TLR5 stimulation on liver
luciferase activity (Figure 1E–F). To this aim, Tlr5-specific shRNA
encoding plasmids were co-administered with the Ccl20-luc
reporter construction by hydrodynamic shock and mice were
stimulated with flagellin. Under these conditions, impairment of
liver TLR5 expression abrogated completely the reporter expres-
sion in response to flagellin (p,0.001) but not LPS (Figure 1E). In
contrast, the control (scramble) shRNA plasmid still displayed
inducible luciferase activity independently of stimulation. Finally,
the requirement of TLR5 signaling was studied using the mouse
counterpart of human dominant negative TLR5, i.e.
mTLR5393stop. Injection of the plasmid encoding mTLR5393stop
was associated to .90% decrease response to flagellin (Figure 1F).
In conclusion, the direct flagellin-TLR5 interaction on liver cells
Figure 3. Luciferase activity is induced by treatment with
flagellin by different routes. Ccl20-luc-IRES-eyfp mice were treated
with flagellin (5 mg) or PBS by i.v. (A) or i.n. (B) route. Lungs were
sampled 4 h later and luciferase activity was measured. Results (n = 7)
are expressed as mean 6 SD (* p,0.05 Mann-Whithney test) and are
representative of two experiments.
doi:10.1371/journal.pone.0078447.g003
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seems to be the major pathway that control Ccl20 early expression
upon systemic flagellin delivery.
Generation and Functional Analysis of Ccl20 Reporter
Mice
The pCcl20-luc plasmid was further engineered to incorporate
the IRES-eyfp cassette downstream of luc cDNA. The resulting
plasmid pCcl20-luc-IRES-eyfp was found to respond as effectively as
pCcl20-luc in the hydrodynamic shock model (Figure 1G).
However, we were not able to detect increase of EYFP
fluorescence in liver of flagellin-stimulated mice (data not shown).
The generation of a stable reporter mouse strain by transgenesis
was then started using the pCcl20-luc-IRES-eyfp DNA at the Institut
Clinique de la Souris. Among several PCR positive founders, 5
clones were selected for expansion as F1 generation and
characterization. The F2 mice derived from three selected F1
founders (clones 61, 68 and 72) were analyzed for the relative
levels of luciferase activity in various organs upon stimulation with
flagellin (Figure S1). The animals derived from clone 61 were
selected for further expansion and analysis. In several tissues of
Ccl20-luc mice derived from clone 61, the luciferase activity was
low or close to background signals at the steady state or after mock
treatment (data not shown). In contrast, the flagellin treatment was
consistently able to induce the expression of reporter fusion as
detected by the increase of the luciferase activity (Figure 2). The
maximal activation was associated with the liver although
significant luciferase activity was observed in lung, spleen, ileum
and colon (Figure 2A). However, Ccl20 reporter fusion expression
was almost undetectable in blood, duodenum and jejunum. These
results highly correlated with the levels of Ccl20 transcripts
(Figure 2B). Indeed, liver Ccl20 mRNA levels were increased
140630 fold upon flagellin stimulation, whereas the increase was
3068 and 863 fold in lung and ileum, respectively. The fusion
expression in liver was also assessed at different times after flagellin
stimulation. We observed a fast induction of luciferase activity
(200650 fold) 4 h post-treatment associated to a gradual decrease
at later time points (Figure 2C). This rapid activation correlates
with a rise in Ccl20 mRNA levels of around 150 fold at 4 h post-
treatment that return to basal levels at 24 h (Figure 2D).
Interestingly, qPCR analysis of genomic DNA derived from F1
to F7 generations revealed that the transgene copy number is
stable as defined by relative levels of genomic DNA specific for
luciferase and beta actin genes (data not shown). Altogether, our
data show that the Ccl20-luc reporter mice represent an
appropriate model to monitor in real time the activity of Ccl20
promoter.
As CCL20 can be induced at various mucosal sites in response
to pro-inflammatory stimuli [14], the activation of the reporter in
lung mucosa after intranasal and systemic flagellin administration
was compared. A significant induction of the luciferase activity was
observed in both cases (Figure 3A).
Real Time Bio-imaging of Ccl20 Promoter Activity
A major use of luciferase reporter fusion is the real time
monitoring of gene expression by bio-imaging [34]. The Ccl20-luc
reporter mouse was used for in vivo imaging studies at different
times after systemic stimulation, i.e. i.v./i.p. administration of
flagellin or heat-inactivated Salmonella (Figure 4). The NF-kB-luc
reporter mice strain that harbors artificial promoter with tandem
NF-kB motifs was used as control to evaluate the intensity of the
pro-inflammatory response [35]. In 4 h-treated NF-kB-luc mice,
flagellin induced a strong luciferase activity in the abdominal
region (liver and gut) and the respiratory tract compared to
untreated mice (Figure 4A). In the same conditions, luciferase
activity was detected in Ccl20-luc-IRES-eyfp mice but was restricted
to the abdomen. The system used for in vivo imaging allows the
quantification of the luminescence emission in defined areas.
Different anatomic regions were defined to get a comparative
analysis of regionalized activation (Figure 4B). The kinetic analysis
performed in Ccl20-luc-IRES-eyfp mice showed that upon flagellin
stimulation, the maximal activity was mainly limited to upper
abdomen, with a peak at 4 h and a progressive decrease to basal
levels at 24 h. In the middle abdomen, a lower luminescence and a
different kinetic (maximum at 8 h) was observed (Figure 4C). The
magnitude of luciferase activity was more important in NFkB-luc
mice than in Ccl20-luc-IRES-eyfp mice, with significant differences
in kinetics and anatomical expression. When Ccl20-luc-IRES-eyfp
mice were stimulated with heat-inactivated Salmonella, luciferase
expression patterns were found to be similar to flagellin-induced
treatment although the global magnitude was higher (Figure 4C
and data not shown). Altogether these results showed that the
Ccl20-luc-IRES-eyfp mice could be used for in vivo real time
imaging. Furthermore, the Ccl20-luc-IRES-eyfp mice showed a
specific pattern of expression to systemic challenge charcterized by
specific activation in the liver.
Discussion
In the present work we have characterized some features of the
Ccl20 promoter and generated the transgenic reporter mouse line
Ccl20-luc-IRES-eyfp that recapitulates the transcriptional activity of
Ccl20 in various organs. We have shown that the transgenic mouse
line can be used for in vivo imaging of CCL20 response,
representing a novel tool for the examination of physiopatholog-
ical situations that may include the CCL20-CCR6 axis as a major
component.
From the initial descriptions of mouse Ccl20 and human CCL20
promoters, the conservation of several features was appreciated.
First, the proximal NF-kB binding site was found to be critical to
the promoter activity in steady state (constitutive) and pathological
(inducible) conditions [15,16,36,37]. We have previously shown
that the NF-kB binding site can bind different NF-kB combina-
tions [19]. When the canonical p65/p50 pro-inflammatory NF-kB
dimer binds the site, a highly inducible CCL20 response is
triggered as a feature of pro-inflammatory stimuli. Besides, the
same site can bind RelB/p52 NF-kB that is involved in the NF-kB
alternative pathway function, thereby promoting a sustained
Figure 4. In vivo imaging shows specific liver response to inflammatory stimuli. A. NFkB-luc and Ccl20-luc-IRES-eyfp mice imaging 4 h after
flagellin (10 mg) i.v. treatment. Image acquisition was performed as indicated in methods section and was stared 1 minute after administration of
luciferin. X-ray and luminescence images are superimposed by the software. Luciferase activity is depicted in a pseudocolored scale, as indicated. Non
transgenic and transgenic-PBS treated mice were used as controls. B. Animal body was arbitrarily divided in different anatomic regions, using the X-
ray image as reference. C. Kinetic analysis of NF-kB-luc and Ccl20-luc-IRES-eyfp mice stimulated i.v. with flagellin (10 mg) or heat-killed Salmonella (108
CFU equivalent). Absolute photon emission was calculated for anatomical regions defined in B. For each acquisition, luciferin was injected 1 minute
before the measurement as stated in A. Results corresponding to each anatomic region are depicted with different symbols, as indicated in each
graph. Mean values and SD for each group are depicted (n = 4).
doi:10.1371/journal.pone.0078447.g004
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transcription of CCL20 encoding gene after engagement of several
TNFR superfamily members such as LTbR or TWEAKR [20,38].
This pathway has been involved in the constitutive expression of
CCL20, particularly in sites such as the follicle associated
epithelium in mucosal sites. By targeted mutations, Kwon et al.
showed that ETS binding sites in the proximal promoter region
were critical for Ccl20 expression in intestinal epithelium [39]. In
this work, we have shown that in the mouse promoter the NF-kB
binding site is critical for in vivo liver inducible activation; however
the ETS site positioned in 2156/2147 is dispensable to this
activity. Among the various ETS transcription factors, the
intestinal epithelium specific ESE-1 transcription factor was shown
to bind the Ccl20 promoter [39] and contribute to the inducible
expression in intestinal epithelium [20]. The high inducible
activity observed in liver may be contributed by other specific
tissue transcription factors that are not acting on ESE-1 binding
site and have not yet been identified.
In concordance with previous reports [37,40], we have observed
that Ccl20 expression upon different pro-inflammatory stimuli is
maximal in liver. LPS, as well as proinflammatory cytokines such
as TNFa, are potent inducers of liver Ccl20 expression [37,41].
Since flagellin stimulation may trigger the production of TNFa by
myeloid cells [42], it may be expected that by systemic
administration of flagellin, CCL20 expression can be contributed
initially by direct PRR-PAMP interaction and secondary by
indirect activation by cytokines such as TNF that are secreted
upon PAMP stimulation. However, we have shown that impairing
TLR5 activity in liver in vivo abrogates completely the CCL20 liver
response, indicating that direct PRR-PAMP interaction is the
main trigger of Ccl20 liver expression in this case (Figure 1). The
kinetics of Ccl20-luc expression observed in vivo upon flagellin or
heat-killed salmonella stimulation supports this hypothesis
(Figures 2 and 4).
We have shown that the transgenic reporter mice are suitable
for in vivo imaging experiments. The capacity of doing a whole
body scanning for luciferase activity allows determining that upon
proinflammatory stimulation, CCL20 production is maximal in
the liver, in coincidence to what was shown by determination of
enzymatic activity and mRNA in a case by case approach
(Figure 2). Other organs that were not included in the screening
such as skin or thymus were not detected as major sites of CCL20
induction in the in vivo imaging analysis. It must be noted that
there are several limitations to this approach. The luciferase
derived green bioluminescence has limited capacity to pass though
tissue, so emission by internal organs should be over a certain
threshold to be detected by the CCD camera used for the
acquisition [43]. This threshold may not be similar for different
body regions, since their proximity to body surface is not necessary
the same. These differences may explain why the luciferase activity
detected in lungs upon flagellin treatment was evident when
analyzed on a lung lysate; however the light emission in thorax
detected by in vivo imaging was almost similar to background
emission.
The in vivo imaging approach allowed us to perform a simple
comparison of activity against the NF-kB-luciferase reporter
mouse strain that harbors an artificial promoter containing
tandem NF-kB binding sites [35] and was widely used to monitor
in vivo NF-kB activation [44]. Although CCL20 expression is
highly dependent on NF-kB activation, the luciferase activity
observed was not equivalent in Ccl20-luc and NFkB-luc mice. For
instance, NFkB-luc mice showed high luciferase activity at steady
state and widespread tissue expression upon pro-inflammatory
stimulation compared to Ccl20-luc-IRES-eyfp mice. The differences
observed between the two reporter mice strains reflect the activity
of their respective promoters. The native mouse Ccl20 promoter
contains several regulatory regions that respond to several
transcriptional modulators including NF-kB. As discussed previ-
ously, specific combinations of transcription factors are required to
activate Ccl20 expression with respects to nature of tissue/cell and
environmental signals.
We have shown that the Ccl20-luc-IRES-eyfp reporter mice
recapitulate CCL20 expression in tissue- and stimuli-specific
manner. This mouse model may constitute an important tool for
research on liver inflammation and on any diseases where CCL20
may constitute an important element of the pathophysiology, such
as NASH [45] autoimmune hepatitis [46] sterile inflammation and
atherosclerosis [47] or ischemia reperfusion injury [48].
Supporting Information
Figure S1 Functional screening on several Ccl20-luc-
IRES-eyfpmice lines originated from different founders.
Ccl20-luc-IRES-eyfp mice from founders #61, #68 and #72 were
treated i.p. with 5 mg flagellin or PBS. Tissues were sampled 4 h
post-treatment and luciferase activity was determined on tissue
lysates. Results are expressed as mean luminescence (n = 5–7).
(TIF)
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